Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fautrel

Showing results (241-250 of 371) with videos related to

Pageof 38
Sort By:
Joint Bone Spine|March 27, 2012
Reproducibility of radiographic hip measurements in adultsRonan Bouttier, Johanne Morvan, Bernard Mazieres, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)|March 31, 2021
Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA studyKrystel Aouad, Philippe Gaudin, Olivier Vittecoq, et al.
Joint Bone Spine|June 28, 2005
Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR)Thao Pham, Pascal Claudepierre, Xavier Deprez, et al.
Seminars in Arthritis and Rheumatism|January 29, 2013
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany)Marion Le Boëdec, Thierry Marhadour, Valérie Devauchelle-Pensec, et al.
Joint Bone Spine|February 3, 2016
Association between hip morphology and prevalence, clinical severity and progression of hip osteoarthritis over 3 years: The knee and hip osteoarthritis long-term assessment cohort resultsBenjamin Bouyer, Bernard Mazieres, Francis Guillemin, et al.
RMD Open|December 22, 2022
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in EuropePeter C Taylor, Bruno Fautrel, Yves Piette, et al.
Rheumatology and Therapy|November 20, 2025
Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European PatientsRieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohortMartin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Clinical Rheumatology|February 23, 2018
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patientsLaure Gossec, John Richard Kirwan, Maarten de Wit, et al.
Pageof 38

Showing results (241-250 of 371) with videos related to

Sort By:
Pageof 38
Joint Bone Spine|March 27, 2012
Reproducibility of radiographic hip measurements in adultsRonan Bouttier, Johanne Morvan, Bernard Mazieres, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)|March 31, 2021
Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA studyKrystel Aouad, Philippe Gaudin, Olivier Vittecoq, et al.
Joint Bone Spine|June 28, 2005
Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR)Thao Pham, Pascal Claudepierre, Xavier Deprez, et al.
Seminars in Arthritis and Rheumatism|January 29, 2013
Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany)Marion Le Boëdec, Thierry Marhadour, Valérie Devauchelle-Pensec, et al.
Joint Bone Spine|February 3, 2016
Association between hip morphology and prevalence, clinical severity and progression of hip osteoarthritis over 3 years: The knee and hip osteoarthritis long-term assessment cohort resultsBenjamin Bouyer, Bernard Mazieres, Francis Guillemin, et al.
RMD Open|December 22, 2022
Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity and advanced therapy use in EuropePeter C Taylor, Bruno Fautrel, Yves Piette, et al.
Rheumatology and Therapy|November 20, 2025
Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European PatientsRieke Alten, Gerd R Burmester, Marco Matucci-Cerinic, et al.
Rheumatology (Oxford, England)|June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohortMartin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Clinical Rheumatology|February 23, 2018
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patientsLaure Gossec, John Richard Kirwan, Maarten de Wit, et al.
Pageof 38